Skip to main content

Global Conference registration is open! Join thought leaders, May 5–8, 2024, in shaping a shared future through discussions on global issues, innovation, and collective progress.

Comment and Support Letters

Government and Policy Engagement
Comment and Support Letters

Read Comment and Support Letters


Request for Information on Gene Therapy Access – US Senate HELP Committee
Comment Letter | January 22, 2024

Statement on the UN General Assembly Zero-Draft Resolution of the “Scope, modalities, format and organization of the High-Level Meeting on Antimicrobial Resistance convened by the President of the General Assembly”
Comment Letter | January 18, 2024

Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act Reintroduction
Letter of Support | September 22, 2023

Implementation of California’s Master Plan for Aging 
Comment Letter | August 24, 2023

FDA Draft Guidance on Decentralized Clinical Trials for Drugs, Biological Products, and Devices
Comment Letter | July 31, 2023

Request for Information on implementation of the Community Disaster Resilience Zones Act of 2022
Comment Letter | July 25, 2023

Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Discussion Draft - US Senate HELP Committee
Comment Letter | July 10, 2023

Digital Asset Market Structure Discussion Draft
Comment Letter | June 13, 2023

Advancing Clinical and Translational Science through Accelerating the Decentralization of Clinical Trials
Comment Letter | May 12, 2023

Statement at Multi-Stakeholder meeting in support of the UN High-Level Meeting on Pandemic Prevention, Preparedness and Response
Comment Letter | May 9, 2023

Expiration of the Public Health Emergency for COVID-19
Comment Letter | April 19, 2023

Medicare Drug Price Negotiation Program Guidance
Comment Letter | April 14, 2023

Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization – US Senate HELP Committee
Comment Letter | March 29, 2023

Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization – US House Energy & Commerce Committee
Comment Letter | March 13, 2023

OSTP RFI on Clinical Research Infrastructure and Emergency Clinical Trials
Comment Letter | December 27, 2022

Patient Perspectives on Gene Therapy Products
Comment Letter | December 15, 2022

End of Year Legislative Package – Retirement Security Provisions
Letter of Support | December 12, 2022

Environmental Protection Agency Greenhouse Gas Reduction Fund
Comment Letter | December 5, 2022

End of Year Legislative Package – Health Provisions
Letter of Support | December 1, 2022

Reauthorization of Food and Drug Administration (FDA) User Fee Programs
Letter of Support | September 7, 2022

Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act (PREVENT Pandemics Act)
Letter of Support | August 2, 2022

The White House Conference on Hunger, Nutrition, and Health 
Comment Letter | July 11, 2022

2023-2026 National Health Security Strategy (NHSS)
Letter of Support | March 11, 2022

Municipal Securities Rulemaking Board (MRSB) on ESG 
Comment Letter | March 8, 2022

Centers for Medicare and Medicaid Services (CMS) Proposed National Coverage Decision
Comment Letter | February 9, 2022

Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT) Pandemics Draft Legislation 
Comment Letter | February 4, 2022

Prescription Drug User Fee Act VII (PDUFA) 
Comment Letter | October 28, 2021

Financial Industry Regulatory Authority (FINRA) Short Sale Disclosures 
Comment Letter | September 29, 2021

Advanced Research Projects Agency for Health (ARPA-H) Request for Information
Comment Letter | July 16, 2021 

Office of Management and Budget (OMB) – Practices for Advancing Equity and Support for Underserved Communities
Comment Letter | July 6, 2021

Food and Drug Administration (FDA) – Medical Device User Fee Act (MDUFA)
Comment Letter | November 25, 2020

Advancing Connectivity during the Coronavirus to Ensure Support for Seniors (ACCESS) Act, S.3517
Letter of Support | May 20, 2020

Department of Transportation (DOT) – Regional Infrastructure Accelerator Program
Comment Letter | March 25, 2020

Request for Information Regarding Tech Sprints
Comment Letter | December 2, 2019

Internal Revenue Service Request for Comment Regarding the Opportunity Zone Proposed Regulations
Comment Letter | March 27, 2019

Policy on No-Action Letters and the Consumer Financial Protection Bureau (CFPB) Product Sandbox
Comment Letter | February 26, 2017​​​

Small Business Administration (SBA) on Regulatory Burden Docket
Comment Letter | November 15, 2017

Alternative Data and Modeling Techniques in the Credit Process
Comment Letter | May 19, 2017

Licensing Manual Draft Supplement on Evaluating Charter Applications from FinTech Companies
Comment Letter | April 10, 2017

Special Purpose National Bank Charters for FinTech Companies
Comment Letter | January 15, 2017

Proposed Guidance for Third-Party Lending
Comment Letter | October 27, 2016

Comments on the Department of the Treasury Notice: Public Input on Expanding Access to Credit Through Online Marketplace Lending
Comment Letter | September 28, 2015